Core Viewpoint - The Chinese microfluidics industry is experiencing rapid growth, supported by favorable government policies aimed at promoting innovation and expansion among domestic companies [2][4][6]. Policy Support - A series of supportive policies have been introduced by the government to foster the development of the microfluidics industry, encouraging innovation and growth among domestic enterprises [2]. - Key policies include: - December 2023: Guidelines for establishing resource-sharing centers in county-level medical services [4]. - March 2023: Notification on centralized procurement and price management for medical consumables [4]. - May 2022: "14th Five-Year" plan promoting advanced biopharmaceuticals, including microfluidic technologies [4]. - March 2021: National economic and social development plan emphasizing disease prevention and control [4]. - February 2021: Development plan for new in vitro diagnostic equipment [4]. Market Growth - The global microfluidics market has grown from $9 billion in 2017 to $26.1 billion in 2023, with a compound annual growth rate (CAGR) of 19.42% [4]. - The Chinese microfluidics market has expanded from approximately $55.2 million in 2017 to $2.41 billion in 2023, reflecting a CAGR of about 27.84% [6]. Industry Applications - The primary application of microfluidics technology is in in vitro diagnostics, accounting for approximately 83% of its usage, with other applications including cell capture and counting [6]. Research Methodology - The research team utilized a combination of desktop research, quantitative surveys, and qualitative analysis to assess the microfluidics industry's market capacity, industry chain, operational characteristics, profitability, and business models [8].